By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lee's Pharmaceutical 

Unit 110-111, Bio-Informatics Centre
No. 2 Science Park West Avenue
Shatin  Hong Kong    China
Phone: 852-2314-1282 Fax: 852-2314-1708


Company News
TOT Biopharm And Lee's Pharmaceutical Signed An Exclusive Licensing Agreement On Monoclonal Antibody Drug TAB014 1/5/2017 6:48:18 AM
Lee's Pharmaceutical And Shenogen Pharma Group To Test Cancer Candidates In Joint Regimen 8/24/2016 10:43:23 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX) And Lee's Pharmaceutical Announce Acceleration Of RGN-259 Development In China 6/1/2016 4:18:30 PM
Solasia Pharma K.K. And Lee's Pharmaceutical Announce License, Promotion And Supply Agreement (The “Agreement”) For Sancuso 11/25/2015 10:45:32 AM
Armetheon And Lee's Pharmaceutical Enter Into Agreement To Develop And Commercialize Tecarfarin In Greater China And Thailand 9/22/2015 11:25:03 AM
Bioquiddity And Lee's Pharmaceutical Enter Agreement To Jointly Commercialize Two Infusion Pharmaceuticals In China, Taiwan, Hong Kong, And Macau 8/24/2015 7:40:41 AM
Week In Review: Lee's Pharmaceutical Pays $50 Million For Novel Cancer Drug From Sorrento Therapeutics, Inc. 10/13/2014 9:36:00 AM
ScinoPharm And Lee's Pharmaceutical Jointly Develop A Number Of Drug Products For The Chinese Market 5/9/2014 7:10:19 AM
Global Partners SillaJen, TRANSGENE (ENX:TNG) And TRANSGENE (ENX:TNG) Confirm Clinical Development Plan For Pexa-Vec 3/26/2014 9:53:54 AM
Lee's Pharmaceutical Gains China Rights To Labor-Inducing Drug 2/20/2014 3:23:10 PM